Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 2,550.00
-60.00 (-2.30%)
At close: Jun 10, 2026
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 33.59 billion as of June 10, 2026. Its market cap has decreased by -76.93% in one year.
Market Cap
33.59B
Enterprise Value
279.80B
Revenue
78.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,550.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 33.59B, an increase of 957.09%. That is a compound annual growth rate of 8.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 34.38B | -66.47% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAMSUNG PHARM. Co., LTD. | 126.78B |
| Kyongbo Pharmaceutical | 125.75B |
| Jeil Pharma Holdings | 112.22B |
| HANDOK | 100.03B |
| CKD Bio | 85.53B |
| Enzychem Lifesciences | 76.86B |
| Ildong Holdings | 74.64B |
| Kukje Pharma | 67.60B |